TissueForm, founded with a mission to improve the lives of individuals with volumetric tissue loss, focuses on harnessing the natural, restorative power of the extracellular matrix. The company advances novel biomaterials designed to address clinical challenges in plastic surgery and regenerative medicine. Their core product is a regenerative tissue-based biomaterial that mimics natural tissue upon injection, aiming to correct and repair large injuries or defects.
Notable affiliated individuals and investors include experts in the fields of regenerative medicine and biomaterials. TissueForm's key achievements include the development and successful application of their innovative biomaterial technology in clinical settings. The overall impact of TissueForm lies in its potential to significantly enhance the quality of life for patients by providing advanced solutions for tissue repair and regeneration.
